Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical trial, blinded, parallel group study to analyze differences in the safety of roflumilast administered once daily on alternate days for two weeks before the regular schedule once a day. [Ensayo clínico, ciego y de grupos paralelos para analizar diferencias en la seguridad de roflumilast administrado una vez al día en días alternos durante dos semanas respecto a la pauta habitual una vez al día]

Next Previous
X
Search
Trial Profile

Clinical trial, blinded, parallel group study to analyze differences in the safety of roflumilast administered once daily on alternate days for two weeks before the regular schedule once a day. [Ensayo clínico, ciego y de grupos paralelos para analizar diferencias en la seguridad de roflumilast administrado una vez al día en días alternos durante dos semanas respecto a la pauta habitual una vez al día]

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Jul 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Roflumilast (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 07 Jul 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Nov 2013 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
    • 08 May 2013 Planned end date changed from 29 Aug 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top